Clinical Trial

Assessing Cancer Treatment Response to Therapy Using 18F-FSPG PET

Recruiting
View on ClinicalTrials.gov →
Summary
Prospective single centre non-randomised exploratory observational study to measure changes in tumour cellular redox status with 18F-FSPG PET in stage 3 non-small cell lung cancer (NSCLC) and stage 3 and 4 head and neck squamous cell cancer (HNSCC) at baseline and during standard of care treatment, and to compare this with 18F-FDG PET/CT and RECIST 1.1 response at 12 weeks.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-05-24.
Status change: Not Yet Recruiting → Recruiting 2025-04-02
Trial Details
NCT Number NCT05889312
Lead Sponsor Guy's and St Thomas' NHS Foundation Trust
Collaborators: King's College London
Conditions Cancer, Diagnosis, Resistant Cancer, Response, Acute Phase
Enrollment 32 participants
Start Date 2025-02-19
Primary Completion 2026-09 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2025-04-04